Hematopoietic Stem Cell Transplantation-associated Thrombotic Microangiopathy
📧 Sign up to get email alerts when something new happens for Hematopoietic Stem Cell Transplantation-associated Thrombotic Microangiopathy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-23FDA Approved: YARTEMLEA — Original Application (Omeros Corporation)
FDA approved the original biologics license application for narsoplimab (brand YARTEMLEA) from Omeros Corporation for hematopoietic stem cel…